IL21 and B-cell chronic lymphocytic leukemia: These results indicate that CLL TFH cells produce abnormally high levels of costimulatory molecules and cytokines known to stimulate CLL survival and proliferation and the expression of IL-21 by these cells is associated with adverse biomarkers and disease burden.